about
Use of simulated patients to evaluate combined oral contraceptive dispensing practices of community pharmacistsImpact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge.Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer.Translation to Brazilian Portuguese and cultural adaptation of a questionnaire addressing high-alert medications.Cost-effectiveness analysis of different dipeptidyl-peptidase 4 inhibitor drugs for treatment of type 2 diabetes mellitus.Perspectives for treating Alzheimer's disease: a review on promising pharmacological substances.Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses.Coronary disease risk assessment in men: Comparison between ASCVD Risk versus Framingham.Study of warfarin utilization in hospitalized patients: analysis of possible drug interactions.Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school.Analysis of treatment of comorbidities and the profile of medical consultations for diabetes mellitus.Pharmacoepidemiologic study of warfarin prescription in a Brazilian tertiary hospital.Factors associated with potentially inappropriate medications use by the elderly according to Beers criteria 2003 and 2012.Drug utilization profile in adult patients with refractory epilepsy at a tertiary referral center.Patients lacking glycemic control place more burdens on health services with the use of medications.Drug-resistant epilepsy and topiramate: plasma concentration and frequency of epileptic seizures.Trastuzumab induced cardiotoxicity in HER2 positive breast cancer patients attended in a tertiary hospital.Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil.Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir.First-wave protease inhibitors for hepatitis C genotype 1 treatment: a real-life experience in Brazilian patientsAnalysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospitalEvaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDAComparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analysesComparison between cardiac risk scales in basic care for different populationsCost-effectiveness analysis is a mandatory strategy for health systems: evidence from a study involving therapies for hepatitis CINSAF-HAS: a tool to select patients with hypertension for pharmaceutical care
P50
Q28535971-B6692202-25E4-4283-8B7E-B50568E04C8FQ36053099-1B81204E-F4A8-4C44-B33F-DF361FF23008Q38128209-627F6F08-41D8-4CF9-89E0-AB4AEEBD5813Q38385828-792232C8-31FE-479D-A5FB-4ED776304A94Q38682129-7B9F7F60-4A12-4106-8A86-BF8249B7B214Q38936146-E4AFF78C-6F45-4694-ABB7-F022031B514BQ38990303-07025552-D978-4F99-8C86-B111E0790CCFQ39167796-1DE3F96A-DAEA-4414-941A-2DE68079083EQ40672590-19B8C625-610C-47FF-B0DB-39FDEC602A24Q42682716-D80C037E-07A4-4D74-9A32-7A302423559FQ43300266-EA1EA3B9-39F3-4F9D-88A7-B663676B7510Q44027927-988F4E4E-895E-4CF8-BA72-A225617CB29DQ44469280-B3801E65-C7D8-474C-B6BC-7B65DDCF01E1Q45393223-0D5C9681-B81C-494C-8B05-9B2710519F23Q47256772-1A61C860-B25B-4B94-B758-90B86CE493B5Q50103071-262443DB-FCA8-4757-BDE3-E2A291634049Q50589569-67884AB3-1575-475F-95D7-8E998C0625A4Q55005060-892E2CE0-A20A-48D1-9DFF-6460FC7BDE72Q55423430-45E4AB9A-6C2B-446D-A8E7-892122D50CC4Q59360878-87AC0672-F7F2-4C47-B014-37938F0BC0CDQ61446572-1159B40D-4D7E-4A7B-B9BF-D628E6324180Q86182890-C60F412C-D503-4066-8B83-EE2EA48C2F73Q88622406-44EF48D9-DD59-43F3-9D8C-BE6CA096669EQ89055512-A7EDBDDA-29A8-4DA0-B891-A5C5D0D3C793Q89541341-7B1B29A9-D298-4518-B874-B6273C3D668FQ92081313-A1F2E3A1-CA51-44B4-AFDA-5CF25483F95E
P50
description
investigador
@es
researcher
@en
name
Leonardo Régis Leira Pereira
@en
type
label
Leonardo Régis Leira Pereira
@en
prefLabel
Leonardo Régis Leira Pereira
@en
P31
P496
0000-0002-8609-1390